TRILO THERAPEUTICS
Trilo Therapeutics, a San Francisco based company founded by biotech/pharma veterans, is developing best-in-class peptide-drug conjugates (PDC) that will address the dose-limiting toxicity of the current generation of ADCs. Trilo novel approach uses macrocyclic D-amino acid peptides to replace the antibody component of ADCs. Our conjugates: - provide superior tumor penetration than ADCs - reduce toxicity compared to traditional L-amino acid peptide-drug conjugates - are compatible with clinically validated payloads and radionuclides - open new treatment modalities based on a "fast in/fast out" mode of action
TRILO THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.trilotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.63 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro SPF Apple Mobile Web Clips Icon Google Font API Google Maps Apache Microsoft Exchange Online
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Trilo Therapeutics
Official Site Inspections
http://www.trilotherapeutics.com Semrush global rank: 7.11 M Semrush visits lastest month: 890
- Host name: biz242.inmotionhosting.com
- IP address: 173.247.244.62
- Location: Santa Monica United States
- Latitude: 34.0125
- Longitude: -118.4682
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90405
More informations about "Trilo Therapeutics"
Trilo Therapeutics - Drugging the Undruggable with Long-Chain …
Trilomer ® Discover Platform Combining the best of antibodies and small molecules Trilomer ® peptidomimetics penetrate tumors faster than antibodies, rapidly deliver a potent …See details»
Trilo Therapeutics - Crunchbase Company Profile
Trilo Therapeutics is developing best-in-class peptide-drug conjugates that address the dose-limiting toxicity of current generation ADCs.See details»
Trilo Therapeutics, Inc. Company Profile | San Francisco, CA ...
Find company research, competitor information, contact details & financial data for Trilo Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Trilo Therapeutics Company Profile | Management and ... - Datanyze
Trilo Therapeutics is a seed-stage company focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes. Trilo's platform of peptidomimetic binders …See details»
Trilo Therapeutics - 2025 Company Profile - Tracxn
Mar 30, 2025 Trilo Therapeutics is a funded company based in Belmont (United States), founded in 2018 by Kurt Gish. It operates as a Developer of protein-protein interaction inhibitors to treat …See details»
Trilo Therapeutics, Inc. - VentureRadar
"Trilo Therapeutics is a seed-stage company focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes. Our platform of peptidomimetic binders …See details»
Trilo Therapeutics - LinkedIn
Trilo Therapeutics | 196 followers on LinkedIn. We develop best-in-class peptide-drug conjugates (PDC) that address the dose-limiting toxicity of ADCs for oncology. | Trilo Therapeutics is a …See details»
Trilo Therapeutics: Revenue, Worth, Valuation & Competitors 2025
About Trilo Therapeutics Trilo Therapeutics is a Biotech related company founded in 2017 and based in Belmont with 4 employees an estimated revenue of $930K, and. It has 10 …See details»
Trilo Therapeutics 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Trilo Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Trilo Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View Trilo Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Trilo Therapeutics - Products, Competitors, Financials, Employees ...
About Trilo Therapeutics Trilo Therapeutics specializes in oncology drug development, focusing on the creation of antibody-drug conjugates (ADCs) and peptide-drug conjugates. The …See details»
Overview, News & Similar companies - ZoomInfo.com
View Trilo Therapeutics (www.trilotherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Trilo Therapeutics - Drugging the Undruggable with Long-Chain …
Kurt Gish, Ph.D., CEO and Co-Founder, Board of Directors Dr. Gish earned his Ph.D. in Biology at Stanford University (thesis advisor: Dr. Charles Yanofsky), followed by a post-doctoral …See details»
Trilo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Trilo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Trilo Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Trilo Therapeutics, Inc. of Belmont, CA. Get the latest business insights from Dun & Bradstreet.See details»
Trilo Therapeutics Overview | SignalHire Company Profile
Overview Trilo Therapeutics is a seed-stage company focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes.See details»
Trilo Therapeutics, Inc. - VentureRadar
Founded in 2017 "Trilo Therapeutics is a seed-stage company focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes. Our platform of …See details»
Trilo Therapeutics, Inc. - Company Profile - Corporation Wiki
View company leaders and background information for Trilo Therapeutics, Inc. Search our database of over 100 million company and executive profiles.See details»
Trilo Therapeutics, Inc. - CMOCRO
Trilo Therapeutics is focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes.See details»
Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human …
2 days ago Frontage Laboratories is a US-based Contract Research Organization (CRO) that was initially established in New Jersey in April 2001 and later relocated to Pennsylvania in 2004.See details»